Back

Pretreatment with P2Y12 inhibitors and relationship with clinical outcomes in NSTEMI: Analysis of 2 Argentinian registries

27 August 2023 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy of acute coronary syndromes in clinical practice Non-ST-Elevation Myocardial Infarction (NSTEMI) ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Alan Rodrigo Sigal

Instituto Cardiovascular De Buenos Aires, Buenos Aires (Argentina)

6 More presentations in this session

Presentation thumbnail
Beta-blockers after STEMI: prognostic impact and predictors of adherence, results from the real-world FAST-STEMI registry
Doctor E. Ravetti (Orbassano, IT)
Abstract Slides Video
Presentation thumbnail
Changes of hospital-level variation in use of optimal medical treatment for long-term follow-up from a multi-level methodological approach
Doctor H. Kwak (Daegu, KR)
Abstract Slides
Presentation thumbnail
Almost 1 in 2 patients with acute coronary syndrome are extremely high-risk and potential candidates for in-hospital triple lipid-lowering therapy: data from the CALLINICUS-Hellas Registry
Professor L. Rallidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy
Professor R. Marcucci (Florence, IT)
Abstract Slides Video
Presentation thumbnail
One-month dual antiplatelet therapy following stent implantation in patients with acute coronary syndromes and high bleeding risk
Doctor C. Pivato (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacotherapy of acute coronary syndromes in clinical practice

The Event

Event poster

ESC Congress 2023

27 August 2023 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Effect of P2Y12 pretreatment on angiographic findings and in-hospital mortality in patients with ST-elevation myocardial infarction
thumbnail
Congress Presentation
Prognostic implications of p2y12 inhibitor pre-treatment in non-st segment elevation acute coronary syndromes undergoing late invasive strategy - a national registry analysis
thumbnail
Congress Presentation
Impact of pretreatment with P2Y12 receptor inhibitors on type 4a myocardial infarction and bleeding in patients with non-ST-segment elevation myocardial infarction: a propensity score matching study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources